At present, in order to cope with the global pandemic of the COVID-19 virus, governments have introduced corresponding measures, COVID-19 lockdown is one of the most important measures. However, lockdown makes the management of chronic diseases (such as type 2 diabetes) more difficult, and telemedicine may be one of the solutions. We hope to explore the effect of telemedicine on blood glucose control and other prognostic indicators of young and middle-aged obese patients with type 2 diabetes who will experience isolation control.
We recruit patients with type 2 diabetes who need to be isolated due to the COVID-19
epidemic, Our study will include young and middle-aged obese patients. The lockdown period is
21 days. The patients will be randomly divided into two groups with a total follow-up time of
6 months. One group is the telemedicine intervention group, and the other group is the
routine follow-up control group. The intervention group used the hospital telemedicine
management system to upload blood glucose values (fasting and 2h after three meals), food
intake of three meals, and exercise volume (Data collection frequency: first three months, 4
times/week; 4-6 Month, 2 times/week).Doctors will collect data from hospital telemedicine
management system to guide patients on diets, exercise, and medication adjustments. The
control group will be followed up by telephone/outpatient clinic every 1 week. (only
telephone follow-up will be conducted during the lockdown period) Then doctors will collect
their blood glucose values.(fasting and 2h after three meals) Based on the data collected,
The doctors will provide lifestyle guidance to the patients on the telephone or face to face.
The clinical data of the two groups of patients will be collected at baseline, 22 days, 3
months, and 6 months respectively. (HbA1c, fasting blood glucose(FBG), blood glucose 2 hours
after breakfast, blood pressure, Body Mass Index(BMI), waist-to-hip ratio, total
cholesterol(TC), triglyceride(TG), high-density lipoprotein cholesterol(HDL-C), low-density
lipoprotein cholesterol(LDL-C), Blood Urea Nitrogen(BUN), serum creatinine(Scr), e-GFR,
Self-rating Depression Scale, frequency of hypoglycemia，and Cost effectiveness) The clinical
data will be statistically analyzed.
Device: Hospital telemedicine management system
Patients upload data of blood glucose, diet and exercise. Then doctors guide patients' diet, exercise and medication adjustment through the telemedicine system.
Other: Usual care
Outpatient/telephone follow-up：continued care, as usual, from their primary care provider through out duration of action 6 months intervention period
Inclusion Criteria:
- Physician diagnosis of Type 2 diabetes for more than 6 months
- 7.0% - Quarantine for 21 days due to COVID-19 outbreak related reasons - age: 18 ~ 55 yrs - BMI≥24 - Be able use smart phones and the Internet Exclusion Criteria: - Insulin pump users - For female subjects: pregnancy or lactation, or subject may become pregnant during the - Patient who underwent obesity surgery to the exclusion of a gastric band, loosened or - Patients diagnosed with COVID-19 infection - Have severe complications (chronic heart disease, cerebrovascular disease, diagnosed
study
removed for more than a year
HIV/AIDS, cancer, emphysema, chronic liver or kidney disease) that would affect the
subjects' ability to follow the tailored advice
Department of Endocrinology, Xuzhou NO.1 Peoples Hospital
Xuzhou, Jiangsu, China
Investigator: Wenwen Yin
Contact: +86 18112008016
wenwen261621@163.com
Wenwen Yin, MD.
+86 18112008016
wenwen261621@163.com
Ning Ding, MD.
+86 17712987026
961897477@qq.com